Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 203.50
+0.50 (0.25%)
Jul 28, 2025, 4:35 PM GMT+1
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 437.35 million as of July 28, 2025. Its market cap has decreased by -11.96% in one year.
Market Cap
437.35M
Enterprise Value
507.61M
Revenue
177.52M
Ranking
n/a
PE Ratio
62.46
Stock Price
203.50
Market Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 437.35M, an increase of 3,837.59%. That is a compound annual growth rate of 15.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 438.43M | 3.50% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | 523.38M | -17.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.50B |
| GSK plc | 56.21B |
| Haleon | 32.84B |
| Smith & Nephew | 10.27B |
| ConvaTec Group | 4.90B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 2.21B |
| Oxford Nanopore Technologies | 2.02B |